These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30480330)

  • 1. Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women.
    Oliveira Filho RV; Antunes NJ; Ilha JO; Moreno RA; Wedemeyer RS; Warnke A; De Nucci G
    Br J Clin Pharmacol; 2019 Mar; 85(3):551-562. PubMed ID: 30480330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels.
    Schiff I; Tulchinsky D; Ryan KJ; Kadner S; Levitz M
    Am J Obstet Gynecol; 1980 Dec; 138(8):1137-41. PubMed ID: 6778214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose pharmacokinetics and pharmacodynamics assessment of oestriol and trimegestone containing vaginal rings in healthy women with childbearing potential.
    de Jesus Antunes N; de Oliveira Filho RV; de Oliveira Ilha J; Moreno RA; Nahoum AF; Wedemeyer RS; Warnke A; De Nucci G
    Eur J Contracept Reprod Health Care; 2021 Jun; 26(3):184-194. PubMed ID: 33645377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U; Mashchak CA; Mishell DR
    Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women.
    Mattsson LA; Cullberg G
    Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicle stimulating hormone, its novel association with sex hormone binding globulin in men and postmenopausal women.
    Wang N; Zhang K; Han B; Li Q; Chen Y; Zhu C; Chen Y; Xia F; Zhai H; Jiang B; Shen Z; Lu Y
    Endocrine; 2017 Jun; 56(3):649-657. PubMed ID: 28260206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of hormone therapy in women during postmenopause with the help of Kliogest].
    Bałajewicz M; Mazanek-Mościcka M
    Ginekol Pol; 1996 Nov; 67(11):561-8. PubMed ID: 9289443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaints.
    Vartiainen J; Wahlström T; Nilsson CG
    Maturitas; 1993 Sep; 17(2):129-37. PubMed ID: 8231904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
    Pfeiler G; Glatz C; Königsberg R; Geisendorfer T; Fink-Retter A; Kubista E; Singer CF; Seifert M
    Climacteric; 2011 Jun; 14(3):339-44. PubMed ID: 21226657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
    Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
    Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
    Keller PJ; Riedmann R; Fischer M; Gerber C
    Maturitas; 1981 Mar; 3(1):47-53. PubMed ID: 6789033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women.
    Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W
    Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of 25-mg estradiol implants in postmenopausal Mexican women.
    del Carmen Cravioto M; Larrea F; Delgado NE; Escobar AR; Díaz-Sánchez V; Domínguez J; de León RP
    Menopause; 2001; 8(5):353-60. PubMed ID: 11528362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR; Elkind-Hirsch KE; Buster JE; Hornsby PJ; Carson SA; Snabes MC
    Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of oestriol in the management of the post-menopause.
    Tzingounis VA; Aksu MF; Greenblatt RB
    Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
    Voipio SK; Komi J; Kangas L; Halonen K; DeGregorio MW; Erkkola RU
    Maturitas; 2002 Nov; 43(3):207-14. PubMed ID: 12443837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.